US Edition
MRCG Participates in Multi-Country Research to Support TB Vaccine Development – Foroyaa Newspaper
Summary by Foroyaa Newspaper
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
MRCG Participates in Multi-Country Research to Support TB Vaccine Development – Foroyaa Newspaper
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains one of the most devastating infectious diseases worldwide. Despite significant advancements in diagnosis and treatment, TB continues to pose a substantial global health burden. According to the World Health Organisation’s 2023 Global TB Report, 10.6 million people were diagnosed with TB in 2022, and 1.3 million people died from the disease, including approximately 167,000 ind…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
